The commercialization of transplantation

Transplantation Proceedings

Volumn 35, Issue 3, 2003, Pages 1235-1237

  Tilney, N L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

CLINICAL PRACTICE; COMMERCIAL PHENOMENA; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUSTRY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL INFORMATION; MEDICAL RESEARCH; ORGAN TRANSPLANTATION; PRESCRIPTION; PRIORITY JOURNAL; TECHNOLOGY; UNITED STATES;

EID: 0038030772     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00202-1     Document Type: Conference Paper

References (18)

1. Zinman J. Nature. 383:1996;751.
2. McArthur J.H., Moore F.D. JAMA. 277:1997;985.
3. Guttman R.D. J Hist Biol. 30:1997;367.
4. Eichenwald K, Kolata G: The New York Times, May 16, 1999.
5. Tilney N.L., Guttman R.D., Daar A.S., et al. Transplant. 71:2001;591.
6. Blumenthal D., Causino N., Campbell E.G., et al. N Engl J Med. 334:1996;368.
7. Campbell E.G., Seashore L.K., Blumenthal D. JAMA. 279:1998;995.
8. Blumenthal D., Campbell E.G., Causino N., et al. N Engl J Med. 335:1996;1734.
9. Haber E. Nature Biotech. 4:1996;441.
10. Angel M. N Engl J Med. 342:2000;1516.
11. Dembner A: Boston Globe, May 21, 2001.
12. Lancet. 359:2002;1704.
13. Rosenthal M.B., Berndt E.R., Donohue J.M., et al. N Engl J Med. 346:2002;498.
14. Thompson D.F. N Engl J Med. 329:1993;573.
15. Kassirer J.M., Angel M. N Engl J Med. 329:1993;570.
16. Levinsky N.G. N Engl J Med. 347:2002;759.
17. Rosenberg S.A. N Engl J Med. 334:1996;392.
18. Deyo R.A., Psaty B.M., Simon G., et al. N Engl J Med. 336:1997;1176.